Cargando…

Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma

BACKGROUND: Lymph node metastasis (LNM) of papillary thyroid carcinoma (PTC) has a certain regularity and occurs first to the central lymph node and then to the lateral lymph node. The pathway of PTC LNM can guide surgical prophylactic lymph node dissection (LND) for clinical surgeons. AIM: To inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing, Li, Da-Xue, Gao, Han, Su, Xin-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100740/
https://www.ncbi.nlm.nih.gov/pubmed/35647144
http://dx.doi.org/10.12998/wjcc.v10.i12.3709
_version_ 1784706920822603776
author Zhou, Jing
Li, Da-Xue
Gao, Han
Su, Xin-Liang
author_facet Zhou, Jing
Li, Da-Xue
Gao, Han
Su, Xin-Liang
author_sort Zhou, Jing
collection PubMed
description BACKGROUND: Lymph node metastasis (LNM) of papillary thyroid carcinoma (PTC) has a certain regularity and occurs first to the central lymph node and then to the lateral lymph node. The pathway of PTC LNM can guide surgical prophylactic lymph node dissection (LND) for clinical surgeons. AIM: To investigate the relationship between subgroups of central LNM and lateral LNM in unilateral clinically node-negative PTC (cN0-PTC). METHODS: Data were collected for 1089 PTC patients who underwent surgical treatment at the Department of Endocrine and Breast Surgery of the First Hospital of Chongqing Medical University from January 2016 to December 2017. A total of 388 unilateral cN0-PTC patients met the inclusion criteria and were enrolled in this study. The clinical and pathological data for these 388 patients who underwent total thyroidectomy + central LND + lateral LND were retrospectively analyzed. The relationship between the central LNM and lateral LNM subgroups was investigated. RESULTS: The coincidence rate of cN0-PTC was only 30.0%.Optimal scaling regression analysis showed that sex (57.1% vs 42.9%, P = 0.026), primary tumor size (68.8% vs 31.2%, P = 0.008), tumor location (59.7% vs 40.3%, P = 0.007), extrathyroid extension (ETE) (50.6% vs 49.9%, P = 0.046), and prelaryngeal LNM (57.1% vs 42.9%, P = 0.004) were significantly associated with ipsilateral level-II LNM. Their importance levels were 0.122, 0.213, 0.172, 0.110, and 0.227, respectively. Primary tumor size (74.6% vs 30.2%, P = 0.016), pretracheal LNM (67.5% vs 32.5%, P < 0.001), and paratracheal LNM (71.4% vs 28.6%, P < 0.001) were significantly associated with ipsilateral level-III LNM. Their importance levels were 0.120, 0.408, and 0.351, respectively. Primary tumor size (72.1% vs 27.9%, P = 0.003), ETE (70.4% vs 29.6%, P = 0.016), pretracheal LNM (68.3% vs 31.7%, P=0.001), and paratracheal LNM (80.8% vs 19.2%, P < 0.001) were significantly associated with ipsilateral level-IV LNM. Their importance levels were 0.164, 0.146, 0.216, and 0.472, respectively. CONCLUSION: The LNM pathway of thyroid cancer has a certain regularity. For unilateral cN0-PTC patients with a tumor diameter > 2 cm and pretracheal or ipsilateral paratracheal LNM, LND at ipsilateral level III and level IV must be considered. When there is a tumor in the upper third of the thyroid with prelaryngeal LNM, LND at level II, level III and level IV must be considered.
format Online
Article
Text
id pubmed-9100740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-91007402022-05-26 Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma Zhou, Jing Li, Da-Xue Gao, Han Su, Xin-Liang World J Clin Cases Retrospective Study BACKGROUND: Lymph node metastasis (LNM) of papillary thyroid carcinoma (PTC) has a certain regularity and occurs first to the central lymph node and then to the lateral lymph node. The pathway of PTC LNM can guide surgical prophylactic lymph node dissection (LND) for clinical surgeons. AIM: To investigate the relationship between subgroups of central LNM and lateral LNM in unilateral clinically node-negative PTC (cN0-PTC). METHODS: Data were collected for 1089 PTC patients who underwent surgical treatment at the Department of Endocrine and Breast Surgery of the First Hospital of Chongqing Medical University from January 2016 to December 2017. A total of 388 unilateral cN0-PTC patients met the inclusion criteria and were enrolled in this study. The clinical and pathological data for these 388 patients who underwent total thyroidectomy + central LND + lateral LND were retrospectively analyzed. The relationship between the central LNM and lateral LNM subgroups was investigated. RESULTS: The coincidence rate of cN0-PTC was only 30.0%.Optimal scaling regression analysis showed that sex (57.1% vs 42.9%, P = 0.026), primary tumor size (68.8% vs 31.2%, P = 0.008), tumor location (59.7% vs 40.3%, P = 0.007), extrathyroid extension (ETE) (50.6% vs 49.9%, P = 0.046), and prelaryngeal LNM (57.1% vs 42.9%, P = 0.004) were significantly associated with ipsilateral level-II LNM. Their importance levels were 0.122, 0.213, 0.172, 0.110, and 0.227, respectively. Primary tumor size (74.6% vs 30.2%, P = 0.016), pretracheal LNM (67.5% vs 32.5%, P < 0.001), and paratracheal LNM (71.4% vs 28.6%, P < 0.001) were significantly associated with ipsilateral level-III LNM. Their importance levels were 0.120, 0.408, and 0.351, respectively. Primary tumor size (72.1% vs 27.9%, P = 0.003), ETE (70.4% vs 29.6%, P = 0.016), pretracheal LNM (68.3% vs 31.7%, P=0.001), and paratracheal LNM (80.8% vs 19.2%, P < 0.001) were significantly associated with ipsilateral level-IV LNM. Their importance levels were 0.164, 0.146, 0.216, and 0.472, respectively. CONCLUSION: The LNM pathway of thyroid cancer has a certain regularity. For unilateral cN0-PTC patients with a tumor diameter > 2 cm and pretracheal or ipsilateral paratracheal LNM, LND at ipsilateral level III and level IV must be considered. When there is a tumor in the upper third of the thyroid with prelaryngeal LNM, LND at level II, level III and level IV must be considered. Baishideng Publishing Group Inc 2022-04-26 2022-04-26 /pmc/articles/PMC9100740/ /pubmed/35647144 http://dx.doi.org/10.12998/wjcc.v10.i12.3709 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Retrospective Study
Zhou, Jing
Li, Da-Xue
Gao, Han
Su, Xin-Liang
Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
title Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
title_full Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
title_fullStr Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
title_full_unstemmed Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
title_short Relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
title_sort relationship between subgroups of central and lateral lymph node metastasis in clinically node-negative papillary thyroid carcinoma
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100740/
https://www.ncbi.nlm.nih.gov/pubmed/35647144
http://dx.doi.org/10.12998/wjcc.v10.i12.3709
work_keys_str_mv AT zhoujing relationshipbetweensubgroupsofcentralandlaterallymphnodemetastasisinclinicallynodenegativepapillarythyroidcarcinoma
AT lidaxue relationshipbetweensubgroupsofcentralandlaterallymphnodemetastasisinclinicallynodenegativepapillarythyroidcarcinoma
AT gaohan relationshipbetweensubgroupsofcentralandlaterallymphnodemetastasisinclinicallynodenegativepapillarythyroidcarcinoma
AT suxinliang relationshipbetweensubgroupsofcentralandlaterallymphnodemetastasisinclinicallynodenegativepapillarythyroidcarcinoma